Healthcare stocks are lower with the NYSE Healthcare Sector
Index declining about 0.4% while shares of healthcare companies in
the S&P 500 slipping 0.8% as a group.
In company news, CEL-SCI Corp. (
) is up 1.7% at $1.23 a share, giving back roughly half of its
earlier gains after this morning saying it has signed a Cooperative
Research and Development Agreement with the Naval Medical Center in
San Diego for Phase I testing of the company's investigational
Leukocyte Interleukin injection in HIV/HPV co-infected men and
women with peri-anal warts.
CVM will contribute the investigational study drug Multikine and
will retain all rights to any currently owned technology and will
have the right to exclusively license any new technology developed
from the collaboration.
In other sector news,
(+) CTIC, Reaches deal with FDA for a Special Protocol
Assessment for Phase III testing of its pacritinib drug candidate
in patients with myelofibrosis.
(-) ATOS, Voluntarily recalls its ForeCYTE Breast Health Test
and the Mammary Aspiration Specimen Cytology Test to "address
concerns raised by the FDA."
Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.